A novel liposomal drug delivery system for PMMA bone cements
Open Access
- 10 August 2015
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 104 (8) , 1510-1524
Abstract
The population in developed countries is ageing and the number of people experiencing joint‐related conditions, such as osteoarthritis, is expected to increase. Joint replacements are currently the most effective treatment for severe joint conditions and although many of these procedures are successful, infection developing after the procedure is still an issue, requiring complex and expensive revisions. Whilst incorporating a powdered antibiotic within the bone cement can reduce infection rates, the powder frequently agglomerates, resulting in poor antibiotic release characteristics and compromised mechanical performance of the cement. To overcome these issues, a novel delivery system consisting of antibiotic‐loaded nano‐sized liposomes was developed for inclusion into polymethyl methacrylate (PMMA) bone cement. This system was tested in a commercial cement (Palacos R) and consistently delivered a higher percentage (22%) of the incorporated antibiotic when compared to the powdered antibiotic cement (9%), meaning less antibiotic needs to be incorporated than with conventional cement. The novel system resulted in a controlled and gradual release of antibiotic over a longer, 30‐day period and enhanced the toughness, bending strength and Vickers hardness of the cement, without altering its polymerization or molecular structure. This new material has the potential to significantly reduce infections in cemented joint replacements leading to enhanced patient quality of life and reduced healthcare costs. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1510–1524, 2016.Keywords
Funding Information
- Arthritis Research UK and Cardiff University (18461)
This publication has 45 references indexed in Scilit:
- Revision in Cemented and Cementless Infected Hip ArthroplastyThe Open Orthopaedics Journal, 2013
- Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyInternational Journal of Nanomedicine, 2011
- Surfactant-stabilized Emulsion Increases Gentamicin Elution From Bone CementClinical Orthopaedics and Related Research, 2011
- Subinhibitory Concentrations of Protein Synthesis-Inhibiting Antibiotics Promote Increased Expression of the agr Virulence Regulator and Production of Phenol-Soluble Modulin Cytolysins in Community-Associated Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2010
- Bone cement: an overviewInternational Journal of Nano and Biomaterials, 2010
- The effect of mixing technique on fatigue of bone cement when stress concentrations are presentInternational Journal of Nano and Biomaterials, 2010
- Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Effect of gentamicin loaded PMMA bone cement onStaphylococcus aureusbiofilm formationBiofouling, 1999
- The effect of interfacial adhesion on toughening behaviour of rubber modified poly(methyl methacrylate)Polymer, 1997
- Liposomes in Drug DeliveryDrugs, 1993